4.7 Article

Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 200, Issue 4, Pages 492-500

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1086/600383

Keywords

-

Funding

  1. Food and Health Bureau of the Hong Kong SAR Government, People's Republic of China

Ask authors/readers for more resources

Background. The goal of this study was to characterize viral loads and factors affecting viral clearance in persons with severe influenza. Methods. This was a 1-year prospective, observational study involving consecutive adults hospitalized with influenza. Nasal and throat swabs were collected at presentation, then daily until 1 week after symptom onset. Real-time reverse-transcriptase polymerase chain reaction to determine viral RNA concentration and virus isolation were performed. Viral RNA concentration was analyzed using multiple linear or logistic regressions or mixed-effect models. Results. One hundred forty-seven inpatients with influenza A (H3N2) infection were studied (mean age +/- standard deviation, years). Viral RNA concentration at presentation positively correlated with symptom 72 +/- 16 scores and was significantly higher than that among time-matched outpatients (control subjects). Patients with major comorbidities had high viral RNA concentration even when presenting >2 days after symptom onset (mean +/- standard deviation, 5.06 +/- 1.85 vs. 3.62 +/- 2.13 log(10) copies/mL; P = .005; beta, +0.86 [95% confidence interval, +0.03 to +1.68]). Viral RNA concentration demonstrated a nonlinear decrease with time; 26% of oseltamivir-treated and 57% of untreated patients had RNA detected at 1 week after symptom onset. Oseltamivir started on or before symptom day 4 was independently associated with an accelerated decrease in viral RNA concentration (mean beta [standard error], -1.19 [0.43] and -0.68 [0.33] log(10) copies/mL for patients treated on day 1 and days 2-3, respectively; P < .05) and viral RNA clearance at 1 week (odds ratio, 0.10 [95% confidence interval, 0.03-0.35] and 0.30 [0.10-0.90] for patients treated on day 1-2 and day 3-4, respectively). Conversely, major comorbidities and systemic corticosteroid use for asthma or chronic obstructive pulmonary disease exacerbations were associated with slower viral clearance. Viral RNA clearance was associated with a shorter hospital stay (7.0 vs 13.5 days;P = .001). Conclusion. Patients hospitalized with severe influenza have more active and prolonged viral replication. Weakened host defenses slow viral clearance, whereas antivirals started within the first 4 days of illness enhance viral clearance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available